Expressed and Silent Carbapenemase Genes Detected by Multiplex PCR in both Carbapenem-Resistant and Phenotypically-Susceptible Gram Negative Bacilli

References

• Kani RKS, Srinivasan B, Glesby MJ, et al. Current state of the art in rapid diagnostics for antimicrobial resistance. Lab Chip 2020; 20(15), 2607–2625.
   Google Scholar
• Zohar I, Schwartz O, Yossepowitch O, et al. Aminoglycoside versus carbapenem or piperacillin/tazobactam treatment for bloodstream infections of urinary source caused by Gram-negative ESBL-producing Enterobacteriaceae. J Antimicrob Chemother 2020; 75(2), 458–465.
   Web of Science ®Google Scholar
• Morris S, Trends CE, Epidemiology, and management of multi-drug resistant gram-negative bacterial infections in the hospitalized setting. Antibiotics 2020; 9(4), 196.
   Google Scholar
• Braun SD, Monecke S, Thürmer A, et al. Rapid identification of carbapenemase genes in gram-negative bacteria with an oligonucleotide microarray-based assay. PLoS One 2014; 9(7): e102232.
   PubMed Web of Science ®Google Scholar
• Jenkins S, Ledeboer NA, Westblade LF, et al. Evaluation of NG-test carba 5 for rapid phenotypic detection and differentiation of five common carbapenemase families: results of a multicenter clinical evaluation. J Clin Microbiol 2020; 58(7), e00344-20. doi:10.1128/JCM.00344-20.
   Web of Science ®Google Scholar
• Centers for Disease Control and Prevention (CDC). Identifying healthcare-associated infections (HAI) for NHSN surveillance. Atlanta, 2018. Centers for Disease Control and Prevention.
   Google Scholar
• Centers for Disease Control and Prevention (CDC). Device-associated Module VAE, 2018.
   Google Scholar
• Collee JG, Marr W Specimen collection, culture containers and media. Mackie & McCartney practical medical microbiology. In: Collee JG, Fraser AG, Marmion BP, et al., editors. New York: Churchill Livingstone; 1996, p. 85–111.
   Google Scholar
• Clinical Laboratory Standards Institute (CLSI). Performance standards for antimicrobial susceptibility testing. 29th ed. Wayne (PA): CLSI Supplement M100; 2019.
   Google Scholar
• European Committee on Antimicrobial Susceptibility Testing (EUCAST). Breakpoint tables for interpretation of MICs and zone diameters. Version 7.1, 2017. [cited 2020 Oct 26]. http://www.eucast.org
   Google Scholar
• Clinical Laboratory Standards Institute (CLSI). Performance standards for antimicrobial susceptibility testing. 27th ed. Wayne (PA): CLSI Supplement M100; 2017.
   Google Scholar
• Kazi M, Drego L, Nikam C, et al. Molecular characterization of carbapenem-resistant Enterobacteriaceae at a tertiary care laboratory in Mumbai. Eur J Clin Microbiol Infect Dis 2015; 34(3), 467–472.
   PubMed Web of Science ®Google Scholar
• Pradhan NP, Bhat SM, Ghadage DP Nosocomial infections in the medical ICU: a retrospective study highlighting their prevalence, microbiological profile and impact on ICU stay and mortality. J Assoc Physicians India 2014; 62(10), 18–21.
   PubMedGoogle Scholar
• Sileem AE, Said AM, Meleha MS Acinetobacter baumannii in ICU patients: A prospective study highlighting their incidence, antibiotic sensitivity pattern and impact on ICU stay and mortality. Egypt J Chest Dis Tuberc, 2017; 66(4), 693–698.
   Web of Science ®Google Scholar
• Mathai AS, Phillips A, Isaac R Ventilator-associated pneumonia: A persistent healthcare problem in Indian intensive care units. Lung India 2016; 33(5), 512–516.
   PubMed Web of Science ®Google Scholar
• American Thoracic Society. Infectious diseases society of America. Guidelines for the management of adults with hospital-acquired, ventilator-associated, and healthcare-associated pneumonia. Am J Respir Crit Care Med 2005; 171: 388–416.
   PubMed Web of Science ®Google Scholar
• Avery LM, Nicolau DP Investigational drugs for the treatment of infections caused by multidrug-resistant Gram-negative bacteria. Expert Opin Inv Drug 2018; 27(4): 325–338.
   PubMed Web of Science ®Google Scholar
• Katchanov J, Asar L, Klupp EM, et al. Carbapenem-resistant Gram-negative pathogens in a German university medical center: prevalence, clinical implications and the role of novel β-lactam/β-lactamase inhibitor combinations. PLoS One 2018; 13(4), e0195757.
   PubMed Web of Science ®Google Scholar
• Bassetti M, Peghin M, Vena A, et al. Treatment of infections due to MDR Gram-negative bacteria. Front Med (Lausanne). 2019; (4) 16; 6:74.
   Google Scholar
• Baran I, Aksu N Phenotypic and genotypic
characteristics of carbapenem-resistant Enterobacteriaceae in a tertiary-level reference hospital in Turkey. Ann Clin Microb Anti 2016; 15(20): 1–11.
   Google Scholar
• Aguirre-Quiñonero A, Martínez-Martínez L Non-molecular detection of carbapenemases in Enterobacteriaceae clinical isolates. J Infect Chemother 2017; 23(1): 1–11.
   Web of Science ®Google Scholar
• Anwar M, Ejaz H, Zafar A, et al. Phenotypic detection of metallo-beta-lactamases in carbapenem resistant acinetobacter baumannii isolated from pediatric patients in Pakistan. J Pathog 2016; 1–6. https://doi.org/10.1155/2016/8603964
   Web of Science ®Google Scholar
• Girlich D, Poirel L, Nordmann P Value of the modified Hodge test for detection of emerging carbapenemases in Enterobacteriaceae. J Clin Microbiol 2011; 50(2): 477–479.
   Web of Science ®Google Scholar
• Zhou M, Wang D, Kudinha T, et al. A comparative evaluation of four phenotypic methods for detection of class A and B carbapenemase-producing Enterobacteriaceae in China. J Clin Microbiol 2018; 56(8): JCM–00395.
   Google Scholar
• Takayama Y, Adachi Y, Nihonyanagi S, et al. Modified Hodge test using Mueller–Hinton agar supplemented with cloxacillin improves screening for carbapenemase-producing clinical isolates of Enterobacteriaceae. J Med Microbiol 2015; 64(7), 774–777.
   Google Scholar
• Doyle D, Peirano G, Lascols C, et al. Laboratory detection of enterobacteriaceae that produce carbapenemases. J Clin Microbiol 2012; 50(12): 3877–3880.
   PubMed Web of Science ®Google Scholar
• Solanki R, Vanjari L, Sreevidya Subramanian AB, et al. Comparative evaluation of multiplex PCR and routine laboratory phenotypic methods for detection of carbapenemases among Gram negative bacilli. J Clin Diagn Res 2014; 8(12), DC23.
   Google Scholar
• Morsi SS Comparative evaluation of phenotypic and genotypic methods for detection of carbapenemases in clinically significant Klebsiella pneumoniae Isolates. Egypt J Med Microbiol 2016; 38(87), 1–8.
   Google Scholar
• Pasteran F, Gonzalez LJ, Albornoz E, et al. Triton Hodge test: improved protocol for modified hodge test for enhanced detection of NDM and other carbapenemase producers. J Clin Microbiol 2015; 54(3), 640–649.
   Web of Science ®Google Scholar
• AlTamimi M, AlSalamah A, AlKhulaifi M, et al. Comparison of phenotypic and PCR methods for detection of carbapenemases production by Enterobacteriaceae. Saudi J Biol Sci 2017; 24(1): 155–161.
   Web of Science ®Google Scholar
• Meletis G, Chatzidimitriou D, Malisiovas N Double- and multi-carbapenemase-producers: the excessively armored bacilli of the current decade. Eur J Clin Microbiol 2015; 34(8), 1487–1493
   Google Scholar